Informing Late-Stage Biomarker Strategies: Learnings from Early In-Human Studies to Inform Future Trial Design
Time: 1:45 pm
day: Conference Day One
Details:
- Going from cell-based assays into symptoms or disease markers for tolerance studies
- Delving into preclinical and clinical development for antigen specific autoimmune disease
